
Elli Peselev
Examiner (ID: 99)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1211, 1203, 1623, 1673, 1802, 2899, 1803, 1621 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8375312
[patent_doc_number] => 08258103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Pesticidal composition'
[patent_app_type] => utility
[patent_app_number] => 12/668625
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7911
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12668625
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668625 | Pesticidal composition | Jul 10, 2008 | Issued |
Array
(
[id] => 6495723
[patent_doc_number] => 20100286077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/667434
[patent_app_country] => US
[patent_app_date] => 2008-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 22517
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286077.pdf
[firstpage_image] =>[orig_patent_app_number] => 12667434
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/667434 | Compound which is a nystatin derivative | Jun 29, 2008 | Issued |
Array
(
[id] => 9711045
[patent_doc_number] => 08835615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => '2′-fluorine-4′-substituted-nucleoside analogues, preparation methods and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/669342
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11942
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12669342
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669342 | 2′-fluorine-4′-substituted-nucleoside analogues, preparation methods and uses thereof | Jun 26, 2008 | Issued |
Array
(
[id] => 4628907
[patent_doc_number] => 08007789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Antibiotics GE 81112 factors A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/147215
[patent_app_country] => US
[patent_app_date] => 2008-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8296
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/007/08007789.pdf
[firstpage_image] =>[orig_patent_app_number] => 12147215
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/147215 | Antibiotics GE 81112 factors A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof | Jun 25, 2008 | Issued |
Array
(
[id] => 5349965
[patent_doc_number] => 20090005326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'SINGLE DOSE ROXITHROMYCIN'
[patent_app_type] => utility
[patent_app_number] => 12/143270
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5683
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20090005326.pdf
[firstpage_image] =>[orig_patent_app_number] => 12143270
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/143270 | SINGLE DOSE ROXITHROMYCIN | Jun 19, 2008 | Abandoned |
Array
(
[id] => 5563712
[patent_doc_number] => 20090136564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'MICELLES'
[patent_app_type] => utility
[patent_app_number] => 12/142608
[patent_app_country] => US
[patent_app_date] => 2008-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6536
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136564.pdf
[firstpage_image] =>[orig_patent_app_number] => 12142608
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/142608 | Micelles | Jun 18, 2008 | Issued |
Array
(
[id] => 6327092
[patent_doc_number] => 20100197624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'ANTHELMINTIC COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 12/666143
[patent_app_country] => US
[patent_app_date] => 2008-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4891
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197624.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666143 | Anthelmintic combination | Jun 15, 2008 | Issued |
Array
(
[id] => 9227500
[patent_doc_number] => 08633168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => 'Inhibitors of S-adenosyl-L-methionine decarboxylase'
[patent_app_type] => utility
[patent_app_number] => 12/664628
[patent_app_country] => US
[patent_app_date] => 2008-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9901
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12664628
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/664628 | Inhibitors of S-adenosyl-L-methionine decarboxylase | Jun 12, 2008 | Issued |
Array
(
[id] => 9166705
[patent_doc_number] => 08592382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-26
[patent_title] => 'Formulations for the oral administration of therapeutic agents and related methods'
[patent_app_type] => utility
[patent_app_number] => 12/601676
[patent_app_country] => US
[patent_app_date] => 2008-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 16326
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12601676
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/601676 | Formulations for the oral administration of therapeutic agents and related methods | May 22, 2008 | Issued |
Array
(
[id] => 4887876
[patent_doc_number] => 20080262208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => '6-11 Bridged Oxime Erythromycin Derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/123874
[patent_app_country] => US
[patent_app_date] => 2008-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16558
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262208.pdf
[firstpage_image] =>[orig_patent_app_number] => 12123874
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/123874 | 6-11 Bridged Oxime Erythromycin Derivatives | May 19, 2008 | Abandoned |
Array
(
[id] => 4675810
[patent_doc_number] => 20080213439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'METHOD FOR PREPARING A COMPOSITION CONTAINING AT LEAST ONE INTERNAL DEHYDRATION PRODUCT FOR A HYDROGENATED SUGAR'
[patent_app_type] => utility
[patent_app_number] => 12/118885
[patent_app_country] => US
[patent_app_date] => 2008-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7274
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12118885
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/118885 | Method for preparing a composition containing at least one internal dehydration product for a hydrogenated sugar | May 11, 2008 | Issued |
Array
(
[id] => 6026893
[patent_doc_number] => 20110054156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'SYNTHESIS OF TIMOSAPONIN BII'
[patent_app_type] => utility
[patent_app_number] => 12/990336
[patent_app_country] => US
[patent_app_date] => 2008-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35463
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20110054156.pdf
[firstpage_image] =>[orig_patent_app_number] => 12990336
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990336 | SYNTHESIS OF TIMOSAPONIN BII | Apr 29, 2008 | Abandoned |
Array
(
[id] => 6616506
[patent_doc_number] => 20100323983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/599657
[patent_app_country] => US
[patent_app_date] => 2008-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3569
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0323/20100323983.pdf
[firstpage_image] =>[orig_patent_app_number] => 12599657
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/599657 | PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF, AND USES THEREOF | Apr 21, 2008 | Abandoned |
Array
(
[id] => 6266593
[patent_doc_number] => 20100298259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME'
[patent_app_type] => utility
[patent_app_number] => 12/599510
[patent_app_country] => US
[patent_app_date] => 2008-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3577
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298259.pdf
[firstpage_image] =>[orig_patent_app_number] => 12599510
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/599510 | PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME | Apr 21, 2008 | Abandoned |
Array
(
[id] => 6266559
[patent_doc_number] => 20100298249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME'
[patent_app_type] => utility
[patent_app_number] => 12/599645
[patent_app_country] => US
[patent_app_date] => 2008-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4178
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298249.pdf
[firstpage_image] =>[orig_patent_app_number] => 12599645
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/599645 | PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME | Apr 21, 2008 | Abandoned |
Array
(
[id] => 4681879
[patent_doc_number] => 20080248105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'POLYMORPHIC FORMS OF 6-11 BICYCLIC KETOLIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/105482
[patent_app_country] => US
[patent_app_date] => 2008-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9909
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248105.pdf
[firstpage_image] =>[orig_patent_app_number] => 12105482
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/105482 | POLYMORPHIC FORMS OF 6-11 BICYCLIC KETOLIDE DERIVATIVES | Apr 17, 2008 | Abandoned |
Array
(
[id] => 5441782
[patent_doc_number] => 20090093421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'ADMINISTRATION OF AVERMECTIN/MILBEMYCIN COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC PATHOLOGIES'
[patent_app_type] => utility
[patent_app_number] => 12/059086
[patent_app_country] => US
[patent_app_date] => 2008-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2623
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093421.pdf
[firstpage_image] =>[orig_patent_app_number] => 12059086
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/059086 | ADMINISTRATION OF AVERMECTIN/MILBEMYCIN COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC PATHOLOGIES | Mar 30, 2008 | Abandoned |
Array
(
[id] => 4698864
[patent_doc_number] => 20080221048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Lyophilized azithromycin formulation'
[patent_app_type] => utility
[patent_app_number] => 12/079770
[patent_app_country] => US
[patent_app_date] => 2008-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11814
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221048.pdf
[firstpage_image] =>[orig_patent_app_number] => 12079770
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/079770 | Lyophilized azithromycin formulation | Mar 26, 2008 | Abandoned |
Array
(
[id] => 6637379
[patent_doc_number] => 20100173858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'COMPOSITIONS TO TREAT BACTERIAL AND INFLAMMATORY AFFECTIONS IN PET ANIMALS DOSAGE FORM AND METHOD TO TREAT PET ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 12/532065
[patent_app_country] => US
[patent_app_date] => 2008-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3909
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173858.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532065
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532065 | Compositions to treat bacterial and inflammatory affections in pet animals dosage form and method to treat pet animals | Mar 23, 2008 | Issued |
Array
(
[id] => 9254658
[patent_doc_number] => 08618074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-31
[patent_title] => 'GPCR enhanced neuroprotection to treat brain injury'
[patent_app_type] => utility
[patent_app_number] => 12/531410
[patent_app_country] => US
[patent_app_date] => 2008-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 23
[patent_no_of_words] => 28939
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12531410
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/531410 | GPCR enhanced neuroprotection to treat brain injury | Mar 16, 2008 | Issued |